Jorge Cortes Healthcare News

Follow[dot]Health is a news alert service for Heathcare and Healthtech. We are following 40K entities across 30M news items - with 1M items added monthly. This is selected healthcare news for Jorge Cortes, which is filed under People. There are 73 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/22/2020 Georgia Cancer Center Offers Skin Cancer Screenings on Phone
... 12:01 a.m. More By TOM CORWIN, Augusta Chronicle AUGUSTA, Ga. (AP) — Dr. Loretta Davis takes the device attached to her iPhone and presses it against a sunspot on the wrist of Dr. Jorge Cortes, the director of the Georgia Cancer Center at Augusta University. After glancing at the sharp ...
U.S. News & World Report
5/29/2020 Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML | Business & Finance |
... phase CML patients who are resistant or intolerant to prior TKIs – which was demonstrated in the 45-mg followed by dose reduction to 15-mg regimen – while maintaining a manageable safety profile,” said Jorge Cortes, MD, Georgia Cancer Center at Augusta University, and an OPTIC trial principal investigator. “It is ...
Business Wire
1/1/2020 UGA researcher featured in Georgia Trend
... at Georgia State University’s Institute for Biomedical Sciences, left, and Russell Allen, president and CEO of the Georgia Research Alliance Credit: Labor Day weekend was a bit of a blur for Dr. Jorge Cortes. As the rest of the country celebrated the end of summer, he and his family ...
11/22/2019 Bio-Path’s Shares Dip on IND Application Approval
11/21/2019 Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002
10/28/2019 Rafael Pharmaceuticals Reaches Milestone of 25 Active Sites for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) Globe Newswire
9/16/2019 Peer-Reviewed Journal Future Oncology Publishes Two Manuscripts on Cancer Metabolism and Drug Candidate CPI-613® (Devimistat) Globe Newswire